Cargando…

Surgical effect and prognostic factors of myasthenia gravis with thymomas

BACKGROUND: To evaluate the surgical effect and prognostic factors of extended thymectomy for myasthenia gravis (MG) patients with thymomas. METHODS: Patients with MG with thymomas who underwent extended thymectomy at Peking University People's Hospital and Beijing Hospital between January 2010...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Wenxin, Li, Xiao, Tong, Hongfeng, Weng, Wenhan, Yang, Fan, Jiang, Guanchao, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180567/
https://www.ncbi.nlm.nih.gov/pubmed/32189468
http://dx.doi.org/10.1111/1759-7714.13396
_version_ 1783525848870027264
author Tian, Wenxin
Li, Xiao
Tong, Hongfeng
Weng, Wenhan
Yang, Fan
Jiang, Guanchao
Wang, Jun
author_facet Tian, Wenxin
Li, Xiao
Tong, Hongfeng
Weng, Wenhan
Yang, Fan
Jiang, Guanchao
Wang, Jun
author_sort Tian, Wenxin
collection PubMed
description BACKGROUND: To evaluate the surgical effect and prognostic factors of extended thymectomy for myasthenia gravis (MG) patients with thymomas. METHODS: Patients with MG with thymomas who underwent extended thymectomy at Peking University People's Hospital and Beijing Hospital between January 2010 and December 2018 were retrospectively enrolled. Patients were followed up by telephone or outpatient record review . Statistical analyses were performed using SPSS version 19.0. RESULTS: A total of 194 patients were included in this study. According to the Osserman classification, there were 56 type I, 52 type IIa, 67 type IIb, 14 type III, and five type IV. Video‐assisted thoracoscopic surgery (VATS) thymectomies were performed in 137 patients, and transthymectomies in 57 patients. The average operation time was 136.6 ± 46.5 minutes, average blood loss was 129.3 ± 287.4 mL, and average postoperative stay was 8.3 ± 7.4 days. A total of 170 patients (87.6%) were successfully followed up. The median follow‐up period was 45 months, and the five‐year overall survival (OS) rate was 81.9%. Cox regression analysis demonstrated that age, Masaoka stage, and recurrence were prognostic factors of OS. Tumor recurrence tended to occur in patients with Masaoka stage III + IV, and age was a protective factor. A total of 20 patients experienced postoperative myasthenic crisis (POMC). Univariate analysis indicated that presence of bulbar symptoms, surgical procedure, and blood loss were risk factors for POMC, but multivariate analysis only indicated the presence of bulbar symptoms as an independent risk factor. A total of 162 patients were evaluated for post intervention MG status. A total of 55 patients achieved complete stable remission; the overall effective rate was 84.5%. Older patients and those with B‐type thymomas had a lower probability of achieving complete stable remission. Efficacy was similar in patients who underwent VATS or the transsternal procedure. CONCLUSIONS: Age, Masaoka stage, and recurrence were prognostic factors of OS. Presence of bulbar symptoms was an independent risk factor for POMC. Age and World Health Organization classification influence the postoperative effect of MG. KEY POINTS: Significant findings of the study Age, Masaoka stage, and recurrence were prognostic factors of OS for MG with thymomas. The presence of bulbar symptoms was an independent risk factor for POMC. Age and World Health Organization classification may influence the postoperative effect of MG. What this study adds Our study had a relatively large sample size of MG patients with thymomas only. We emphasize the analysis of the postoperative effect of MG and overall survival for these patients, which is a complement to previous studies.
format Online
Article
Text
id pubmed-7180567
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-71805672020-05-01 Surgical effect and prognostic factors of myasthenia gravis with thymomas Tian, Wenxin Li, Xiao Tong, Hongfeng Weng, Wenhan Yang, Fan Jiang, Guanchao Wang, Jun Thorac Cancer Original Articles BACKGROUND: To evaluate the surgical effect and prognostic factors of extended thymectomy for myasthenia gravis (MG) patients with thymomas. METHODS: Patients with MG with thymomas who underwent extended thymectomy at Peking University People's Hospital and Beijing Hospital between January 2010 and December 2018 were retrospectively enrolled. Patients were followed up by telephone or outpatient record review . Statistical analyses were performed using SPSS version 19.0. RESULTS: A total of 194 patients were included in this study. According to the Osserman classification, there were 56 type I, 52 type IIa, 67 type IIb, 14 type III, and five type IV. Video‐assisted thoracoscopic surgery (VATS) thymectomies were performed in 137 patients, and transthymectomies in 57 patients. The average operation time was 136.6 ± 46.5 minutes, average blood loss was 129.3 ± 287.4 mL, and average postoperative stay was 8.3 ± 7.4 days. A total of 170 patients (87.6%) were successfully followed up. The median follow‐up period was 45 months, and the five‐year overall survival (OS) rate was 81.9%. Cox regression analysis demonstrated that age, Masaoka stage, and recurrence were prognostic factors of OS. Tumor recurrence tended to occur in patients with Masaoka stage III + IV, and age was a protective factor. A total of 20 patients experienced postoperative myasthenic crisis (POMC). Univariate analysis indicated that presence of bulbar symptoms, surgical procedure, and blood loss were risk factors for POMC, but multivariate analysis only indicated the presence of bulbar symptoms as an independent risk factor. A total of 162 patients were evaluated for post intervention MG status. A total of 55 patients achieved complete stable remission; the overall effective rate was 84.5%. Older patients and those with B‐type thymomas had a lower probability of achieving complete stable remission. Efficacy was similar in patients who underwent VATS or the transsternal procedure. CONCLUSIONS: Age, Masaoka stage, and recurrence were prognostic factors of OS. Presence of bulbar symptoms was an independent risk factor for POMC. Age and World Health Organization classification influence the postoperative effect of MG. KEY POINTS: Significant findings of the study Age, Masaoka stage, and recurrence were prognostic factors of OS for MG with thymomas. The presence of bulbar symptoms was an independent risk factor for POMC. Age and World Health Organization classification may influence the postoperative effect of MG. What this study adds Our study had a relatively large sample size of MG patients with thymomas only. We emphasize the analysis of the postoperative effect of MG and overall survival for these patients, which is a complement to previous studies. John Wiley & Sons Australia, Ltd 2020-03-19 2020-05 /pmc/articles/PMC7180567/ /pubmed/32189468 http://dx.doi.org/10.1111/1759-7714.13396 Text en © 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Tian, Wenxin
Li, Xiao
Tong, Hongfeng
Weng, Wenhan
Yang, Fan
Jiang, Guanchao
Wang, Jun
Surgical effect and prognostic factors of myasthenia gravis with thymomas
title Surgical effect and prognostic factors of myasthenia gravis with thymomas
title_full Surgical effect and prognostic factors of myasthenia gravis with thymomas
title_fullStr Surgical effect and prognostic factors of myasthenia gravis with thymomas
title_full_unstemmed Surgical effect and prognostic factors of myasthenia gravis with thymomas
title_short Surgical effect and prognostic factors of myasthenia gravis with thymomas
title_sort surgical effect and prognostic factors of myasthenia gravis with thymomas
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180567/
https://www.ncbi.nlm.nih.gov/pubmed/32189468
http://dx.doi.org/10.1111/1759-7714.13396
work_keys_str_mv AT tianwenxin surgicaleffectandprognosticfactorsofmyastheniagraviswiththymomas
AT lixiao surgicaleffectandprognosticfactorsofmyastheniagraviswiththymomas
AT tonghongfeng surgicaleffectandprognosticfactorsofmyastheniagraviswiththymomas
AT wengwenhan surgicaleffectandprognosticfactorsofmyastheniagraviswiththymomas
AT yangfan surgicaleffectandprognosticfactorsofmyastheniagraviswiththymomas
AT jiangguanchao surgicaleffectandprognosticfactorsofmyastheniagraviswiththymomas
AT wangjun surgicaleffectandprognosticfactorsofmyastheniagraviswiththymomas